Switch theme
Sign up to access all valuation multiples
Plant Advanced Technologies Pat SA is a France-based life sciences company focusing on eco-friendly plant extracts production for pharmaceutical and cosmetic industries. It is also engaged in R & D in the field of plant biotechnology.
2005
35
LTM Revenue n/a
LTM EBITDA n/a
$18.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Plant Advanced has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Plant Advanced achieved revenue of $1.8M and an EBITDA of $0.1M.
Plant Advanced expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Plant Advanced valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7M | $1.8M | XXX | XXX | XXX |
| Gross Profit | $2.2M | $2.2M | XXX | XXX | XXX |
| Gross Margin | 133% | 121% | XXX | XXX | XXX |
| EBITDA | -$0.7M | $0.1M | XXX | XXX | XXX |
| EBITDA Margin | -41% | 4% | XXX | XXX | XXX |
| Net Profit | -$0.9M | -$0.4M | XXX | XXX | XXX |
| Net Margin | -56% | -24% | XXX | XXX | XXX |
| Net Debt | $4.6M | $5.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Plant Advanced's stock price is EUR 10 (or $11).
Plant Advanced has current market cap of EUR 11.7M (or $12.6M), and EV of EUR 16.8M (or $18.0M).
See Plant Advanced trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18.0M | $12.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Plant Advanced has market cap of $12.6M and EV of $18.0M.
Plant Advanced's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Plant Advanced's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Plant Advanced and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $18.0M | XXX | XXX | XXX |
| EV/Revenue | 10.0x | XXX | XXX | XXX |
| EV/EBITDA | 231.0x | XXX | XXX | XXX |
| P/E | 148.0x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -7420.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPlant Advanced's NTM/LTM revenue growth is n/a
Plant Advanced's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Plant Advanced's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Plant Advanced's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Plant Advanced and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -111% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 164% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Plant Advanced acquired XXX companies to date.
Last acquisition by Plant Advanced was XXXXXXXX, XXXXX XXXXX XXXXXX . Plant Advanced acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Plant Advanced founded? | Plant Advanced was founded in 2005. |
| Where is Plant Advanced headquartered? | Plant Advanced is headquartered in France. |
| How many employees does Plant Advanced have? | As of today, Plant Advanced has 35 employees. |
| Is Plant Advanced publicy listed? | Yes, Plant Advanced is a public company listed on PAR. |
| What is the stock symbol of Plant Advanced? | Plant Advanced trades under ALPAT ticker. |
| When did Plant Advanced go public? | Plant Advanced went public in 2009. |
| Who are competitors of Plant Advanced? | Similar companies to Plant Advanced include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Plant Advanced? | Plant Advanced's current market cap is $12.6M |
| What is the current revenue growth of Plant Advanced? | Plant Advanced revenue growth between 2023 and 2024 was 9%. |
| Is Plant Advanced profitable? | Yes, Plant Advanced is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
